Thursday, 26 August 2010

Suprelorin




Suprelorin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Suprelorin



Deslorelin

Deslorelin acetate (a derivative of Deslorelin) is reported as an ingredient of Suprelorin in the following countries:


  • Australia

  • France

  • Germany

  • New Zealand

  • Switzerland

International Drug Name Search

Tuesday, 24 August 2010

Langa Dip




Langa Dip may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Langa Dip



Cypermethrin

Cypermethrin is reported as an ingredient of Langa Dip in the following countries:


  • South Africa

International Drug Name Search

Monday, 23 August 2010

Uridoz




Uridoz may be available in the countries listed below.


Ingredient matches for Uridoz



Fosfomycin

Fosfomycin tromethamine (a derivative of Fosfomycin) is reported as an ingredient of Uridoz in the following countries:


  • France

International Drug Name Search

Sunday, 22 August 2010

Saleco




Saleco may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Saleco



Salinomycin

Salinomycin sodium salt (a derivative of Salinomycin) is reported as an ingredient of Saleco in the following countries:


  • Australia

International Drug Name Search

Friday, 20 August 2010

Fotemustine




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01AD05

CAS registry number (Chemical Abstracts Service)

0092118-27-9

Chemical Formula

C9-H19-Cl-N3-O5-P

Molecular Weight

315

Therapeutic Category

Antineoplastic agent

Chemical Name

(±)-Diethyl [1-[3-(2-chloroethyl)-3-nitrosoureido]ethyl]phosphonate

Foreign Names

  • Fotemustinum (Latin)
  • Fotemustin (German)
  • Fotémustine (French)
  • Fotemustina (Spanish)

Generic Names

  • Fotemustine (OS: BAN)
  • Fotémustine (OS: DCF)
  • S 10036 (IS: Servier)

Brand Names

  • Fotemustine
    Asia Pioneer, China; Shanghai Pharma Group, China


  • Muforan
    Pfizer, Argentina


  • Muphoran
    Italfarmaco, Italy; Servier, Austria; Servier, Australia; Servier, Belgium; Servier, Brazil; Servier, China; Servier, France; Servier, Greece; Servier, Israel; Servier, Luxembourg; Servier, Turkey


  • Mustoforan
    Italfarmaco, Spain


  • Mustophoran
    Servier, Czech Republic; Servier, Hungary; Servier, Latvia; Servier, Poland; Servier, Romania; Servier, Russian Federation; Servier, Slovakia

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 19 August 2010

Tibolux




Tibolux may be available in the countries listed below.


Ingredient matches for Tibolux



Tibolone

Tibolone is reported as an ingredient of Tibolux in the following countries:


  • Peru

International Drug Name Search

Sunday, 15 August 2010

Butylpan




Butylpan may be available in the countries listed below.


Ingredient matches for Butylpan



Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Butylpan in the following countries:


  • Japan

International Drug Name Search

Cilosmerck




Cilosmerck may be available in the countries listed below.


Ingredient matches for Cilosmerck



Cilostazol

Cilostazol is reported as an ingredient of Cilosmerck in the following countries:


  • Japan

International Drug Name Search

Saturday, 14 August 2010

Nasocalma




Nasocalma may be available in the countries listed below.


Ingredient matches for Nasocalma



Ephedrine

Ephedrine is reported as an ingredient of Nasocalma in the following countries:


  • Portugal

International Drug Name Search

Sunday, 8 August 2010

Bismuth Subsalicylate Chewable Tablets


Pronunciation: BIZ-muth sub-sa-LIS-a-late
Generic Name: Bismuth Subsalicylate
Brand Name: Examples include Bismatrol and Pepto-Bismol


Bismuth Subsalicylate Chewable Tablets are used for:

Treating heartburn, upset stomach, indigestion, nausea, diarrhea, or symptoms associated with eating or drinking too much. It may be used to decrease the number of bowel movements and make the stool firmer. It may also be used to treat other conditions as determined by your doctor.


Bismuth Subsalicylate Chewable Tablets are a salicylate. The way that it works is not fully understood. It is thought to limit secretions in the digestive tract, reduce inflammation in the stomach and intestines, and inhibit the growth of certain bacteria and viruses that can cause intestinal tract diseases.


Do NOT use Bismuth Subsalicylate Chewable Tablets if:


  • you are allergic to any ingredient in Bismuth Subsalicylate Chewable Tablets

  • you have had a severe allergic reaction (eg, severe rash, hives, difficulty breathing, dizziness) to aspirin or a nonsteroidal anti-inflammatory drug (NSAID) (eg, ibuprofen, naproxen, celecoxib)

  • you have bleeding problems (eg, hemophilia), active bleeding ulcer, black or bloody stools, or Von Willebrand disease

  • you are taking another salicylate medicine (eg, aspirin)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Bismuth Subsalicylate Chewable Tablets:


Some medical conditions may interact with Bismuth Subsalicylate Chewable Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have diabetes, gout, arthritis, fever, mucus in the stool, inflammation of the stomach, Kawasaki syndrome, kidney problems, chickenpox, the flu, or joint problems (in children), or if you are dehydrated

  • if you have a history of stroke or a certain type of bulging blood vessel (aneurysm) in the brain

Some MEDICINES MAY INTERACT with Bismuth Subsalicylate Chewable Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Insulin, methotrexate, or valproic acid because actions and side effects may be increased by Bismuth Subsalicylate Chewable Tablets

  • Angiotensin-converting enzyme (ACE) inhibitors (eg, lisinopril) or sulfinpyrazone because their effectiveness may be decreased by Bismuth Subsalicylate Chewable Tablets

  • Anticoagulants (eg, warfarin) because the risk of bleeding may be increased by Bismuth Subsalicylate Chewable Tablets

  • Salicylates (eg, aspirin) because the risk of side effects or toxic effects may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Bismuth Subsalicylate Chewable Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Bismuth Subsalicylate Chewable Tablets:


Use Bismuth Subsalicylate Chewable Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Bismuth Subsalicylate Chewable Tablets may be taken with or without food.

  • Do not take tetracyclines (eg, doxycycline) within 2 hours before or after taking Bismuth Subsalicylate Chewable Tablets.

  • Use Bismuth Subsalicylate Chewable Tablets exactly as directed on the package, unless instructed differently by your doctor.

  • Do not take Bismuth Subsalicylate Chewable Tablets with aspirin.

  • Chew thoroughly before swallowing.

  • Drinking extra fluids while you are taking Bismuth Subsalicylate Chewable Tablets are recommended. Check with your doctor for instructions.

  • If you miss a dose of Bismuth Subsalicylate Chewable Tablets and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Bismuth Subsalicylate Chewable Tablets.



Important safety information:


  • If the packaging blister is torn or open, do not use that particular tablet.

  • Do not exceed the recommended dose or take Bismuth Subsalicylate Chewable Tablets for longer than 48 hours without checking with your doctor. If your symptoms do not improve within 48 hours or if they become worse or you develop a fever, check with your doctor.

  • Bismuth Subsalicylate Chewable Tablets may color the tongue or stool gray or black. This is a temporary and harmless effect.

  • Do not give Bismuth Subsalicylate Chewable Tablets to a child or teenager who has chickenpox, the flu, or another viral infection. Use of Bismuth Subsalicylate Chewable Tablets for treating the symptoms of a viral infection may cause a serious illness called Reye syndrome.

  • Use Bismuth Subsalicylate Chewable Tablets with extreme caution in CHILDREN because they may be more sensitive to its effects.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Bismuth Subsalicylate Chewable Tablets during pregnancy. Bismuth Subsalicylate Chewable Tablets are excreted in breast milk. Do not breast-feed while taking Bismuth Subsalicylate Chewable Tablets.


Possible side effects of Bismuth Subsalicylate Chewable Tablets:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Temporary and harmless darkening of the tongue or stool.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fever; hearing loss; nausea; ringing in the ears; severe constipation; vomiting.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Bismuth Subsalicylate side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include coma; confusion; dehydration; dizziness; new or worsening nausea; ringing in the ears; seizures; unusual bruising or bleeding; vomiting.


Proper storage of Bismuth Subsalicylate Chewable Tablets:

Store Bismuth Subsalicylate Chewable Tablets at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Keep Bismuth Subsalicylate Chewable Tablets out of the reach of children and away from pets.


General information:


  • If you have any questions about Bismuth Subsalicylate Chewable Tablets, please talk with your doctor, pharmacist, or other health care provider.

  • Bismuth Subsalicylate Chewable Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Bismuth Subsalicylate Chewable Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Bismuth Subsalicylate resources


  • Bismuth Subsalicylate Side Effects (in more detail)
  • Bismuth Subsalicylate Dosage
  • Bismuth Subsalicylate Use in Pregnancy & Breastfeeding
  • Drug Images
  • Bismuth Subsalicylate Drug Interactions
  • Bismuth Subsalicylate Support Group
  • 4 Reviews for Bismuth Subsalicylate - Add your own review/rating


Compare Bismuth Subsalicylate with other medications


  • Diarrhea
  • Diarrhea, Chronic
  • Helicobacter Pylori Infection
  • Indigestion
  • Lymphocytic Colitis

Friday, 6 August 2010

Spectrum




Spectrum may be available in the countries listed below.


Ingredient matches for Spectrum



Ceftazidime

Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Spectrum in the following countries:


  • Italy

International Drug Name Search

Potassium Chloride




In some countries, this medicine may only be approved for veterinary use.


In the US, Potassium Chloride (potassium chloride systemic) is a member of the drug class minerals and electrolytes and is used to treat Hypokalemia and Prevention of Hypokalemia.

US matches:

  • Potassium Chloride

  • Potassium Chloride Controlled-Release Tablets

  • Potassium Chloride Extended-Release Capsules

  • Potassium Chloride Extended-Release Tablets

  • Potassium Chloride Liquid

  • Potassium Chloride Powder

  • Potassium Chloride Solution

  • Potassium Chloride Capsules

  • Potassium Chloride Injection Concentrate

  • Potassium Chloride Oral Solution

  • Potassium Chloride in Dextrose and Sodium Chloride

Scheme

Ph. Int.

ATC (Anatomical Therapeutic Chemical Classification)

A12BA01,B05XA01

CAS registry number (Chemical Abstracts Service)

0007447-40-7

Chemical Formula

KCl

Molecular Weight

74

Therapeutic Categories

Electrolyte solution

Treatment of potassium deficiency

Treatment of alkalosis

Chemical Name

Potassium chloride

Foreign Names

  • Kalii chloridum (Latin)
  • Kalium chlorid (German)
  • Potassium chlorure de (French)
  • Potasio cloruro (Spanish)

Generic Names

  • Potassium Chloride (OS: JAN, USAN)
  • E 508 (IS)
  • UNII-660YQ98I10 (IS)
  • Kalii chloridum (PH: Ph. Int. 4, Ph. Eur. 6)
  • Kaliumchlorid (PH: Ph. Eur. 6)
  • Potassio cloruro (PH: F.U. XII)
  • Potassium (chlorure de) (PH: Ph. Eur. 6)
  • Potassium Chloride (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XV)

Brand Names

  • 1 M-Kaliumchlorid-Lösung DeltaSelect
    DeltaSelect, Germany


  • 1 M-Kaliumchlorid-Lösung Fresenius
    Fresenius, Germany


  • Addex-Kaliumklorid
    Fresenius, Sweden; Fresenius, Finland; Fresenius, Norway


  • Ap Inyect Solucion Cloruro Potasico
    Fresenius, Spain


  • Apo-K
    Apotex, Canada


  • Beta K (veterinary use)
    Bomac, New Zealand; Vetsearch International, Australia


  • Burinex med Kaliumklorid (Potassium Chloride and Bumetanide)
    LEO Pharma, Denmark


  • Centyl K (Potassium Chloride and Bendroflumethiazide)
    IFET, Greece; Leo Pharma, United Kingdom


  • Centyl K mite (Potassium Chloride and Bendroflumethiazide)
    LEO, Sweden


  • Centyl med Kaliumklorid (Potassium Chloride and Bendroflumethiazide)
    Leo, Norway; LEO Pharma, Denmark


  • Chloropotassuril
    Melisana, Belgium; Melisana, Luxembourg


  • Chlorure de Potassium
    Siphat, Tunisia; Unimed, Tunisia


  • Chlorure de Potassium 20% Renaudin
    Renaudin, France


  • Chlorure de Potassium B. Braun
    Braun, France


  • Chlorure de Potassium Biosedra
    Fresenius, France


  • Chlorure de Potassium Cooper
    Cooper, France


  • Chlorure de Potassium hypertonique Fresenius
    Fresenius, France


  • Chlorure de Potassium Lavoisier
    Chaix et du Marais, France


  • Chlorure de Potassium Proamp
    Aguettant, France


  • Chlorure de Potassium Renaudin
    Renaudin, France


  • Clorato Potasico Brum
    Brum, Spain


  • Clorato Potasico Orravan
    Orravan, Spain


  • Cloreto de potássio
    Novartis, Portugal


  • Clorpotasium
    Trifarma, Peru


  • Clorurã de Potasiu
    Braun, Romania


  • Cloruro de potasio Apolo
    Apolo, Argentina


  • Cloruro de potasio Biocrom
    Biocrom, Argentina


  • Cloruro de potasio Biol
    Biol, Argentina


  • Cloruro de potasio Drawer
    Drawer, Argentina


  • Cloruro de Potasio Ecar
    Ecar, Colombia


  • Cloruro de Potasio Fabra
    Fabra, Argentina


  • Cloruro de potasio Larjan
    Veinfar, Argentina


  • Cloruro de potasio Northia
    Northia, Argentina


  • Cloruro de Potasio
    Bestpharma, Chile; Biosano, Chile; Farmionni, Colombia


  • Cloruro Potasico Braun
    Braun, Spain


  • Cloruro Potasico Grifols
    Grifols, Spain


  • Conclyte-K1
    Nipro PharmaNipurofama, Japan


  • Control-K
    Merck, Argentina


  • Corozell (Potassium Chloride and Magnesium Aspartate)
    Fresenius Kabi, Austria


  • Co-Salt
    Pfizer, Argentina


  • Diffu-K
    UCB, France


  • Diumide-K (Potassium Chloride and Furosemide)
    Teofarma, United Kingdom


  • Duro-K
    Novartis, Australia


  • Electro-K
    Acme, Bangladesh


  • Faringenilo (Potassium Chloride and Benzocaine)
    Diafarm, Spain


  • F-Zuren
    K Sioe SeiyakuShioe, Japan


  • Glucose KCl Infusion
    Baxter, New Zealand


  • Glucose, NaCl, KCl Infusion
    Baxter, New Zealand


  • Hemodial B
    Trifarma, Peru


  • K Supply
    Sato Seiyaku, Japan


  • K.C.L
    Maruishi, Japan


  • K+ 10
    Alra, United States


  • K+ 8
    Alra, United States


  • K+ Care
    Alra, United States


  • K-10
    GlaxoSmithKline, Canada


  • Kaion Retard
    Andromaco, Chile


  • Kaldyum
    Egis, Hungary; Egis, Poland; Egis, Slovakia


  • Kaleorid
    Leo, France; Leo, Iceland; Leo, Norway; Leo, Sweden; LEO Pharma, Denmark; LEO Pharma, Vietnam


  • Kalii Chloridi
    Lekarna, Slovenia


  • Kalij klorid Jadran
    Jadran, Croatia (Hrvatska); Salus, Slovenia


  • Kalij klorid
    HZTM, Croatia (Hrvatska); Jadran, Bosnia & Herzegowina; Pliva, Croatia (Hrvatska)


  • Kalijum hlorid
    Jadran, Serbia; Sigmapharm, Serbia


  • Kalimat prolongatum
    Lek, Poland


  • Kalinorm
    Leiras, Finland


  • Kalinor-retard P
    Abbott, Germany; Abbott, Luxembourg


  • Kalio chloridas GSK
    GlaxoSmithKline, Lithuania


  • Kalio chloridas Valentis
    Valentis, Lithuania


  • Kaliolite
    Merck, Mexico


  • Kalipoz prolongatum
    GlaxoSmithKline, Poland


  • Kalisol
    Orion, Finland


  • Kalitrans
    Fresenius, Luxembourg


  • Kalitrans-Retard
    Stada, Luxembourg


  • Kalium Chloratum Biomedica
    Biomedica, Czech Republic


  • Kalium Chloratum Infusia
    Infusia, Czech Republic


  • Kalium Chloratum Leciva
    Zentiva, Czech Republic; Zentiva, Slovakia


  • Kalium chloratum Sintetica
    Sintetica, Switzerland


  • Kalium Chloratum
    Briz, Latvia; Pharmamagist, Hungary; Polfa Warszawa, Poland


  • Kalium Chlorid Fresenius
    Fresenius, Luxembourg; Fresenius, Serbia


  • Kalium Chlorid
    Fresenius, Luxembourg


  • Kalium Chlorid-Braun
    Braun Melsungen, Luxembourg


  • Kalium Durettes
    AstraZeneca, Luxembourg


  • Kalium Durules
    Teva, Hungary


  • Kalium Hausmann
    Vifor, Switzerland


  • Kalium
    Polfarmex, Poland


  • Kaliumchlorid B.Braun
    B. Braun Medical, Switzerland; B.Braun, Germany; Braun, Austria; Braun, Hungary; Braun, Luxembourg; Braun, Slovakia


  • Kaliumchlorid Bichsel
    Bichsel, Switzerland


  • Kaliumchlorid Fresenius
    Fresenius, Luxembourg; Fresenius Kabi, Austria


  • Kaliumchloride PCH
    Pharmachemie, Netherlands


  • Kaliumchloride
    Braun, Netherlands; Fresenius, Netherlands


  • Kaliumchlorid-Köhler
    Köhler, Germany


  • Kaliumchlorid-Lösung Baxter
    Baxter, Germany


  • Kaliumchlorid-Lösung Bernburg
    Bernburg, Germany


  • Kaliumklorid "PS"
    Pharma-Skan, Denmark


  • Kaliumklorid "SAD"
    Amgros, Denmark


  • Kaliumklorid B. Braun
    B.Braun Melsungen AGDE, Denmark


  • Kaliumklorid Braun
    Braun, Finland


  • Kalium-Klorid-Teva
    Teva, Hungary


  • Kalium-R
    Valeant, Hungary


  • Kalnormin
    ICN, Czech Republic; ICN, Slovakia


  • Kaochlor
    Savage, United States


  • Kaon-Cl
    Savage, United States


  • Kay Ciel
    Forest, United States


  • Kay-Cee-L
    Geistlich, United Kingdom; Geistlich, Ireland


  • KCl ACS Dobfar Info
    ACS Dobfar Info, Switzerland


  • KCl Sintetica
    Sintetica, Switzerland


  • KCL
    Terumo, Japan


  • KCl-retard Hausmann
    Vifor, Switzerland


  • KCl-retard Zyma
    Novartis, Switzerland; Novartis, Germany; Novartis Consumer Health, Austria


  • KCL-Retard
    Astellas, Italy


  • K-Dur
    Schering-Plough, Canada; Schering-Plough, Mexico


  • Kelefusin
    Pisa, Mexico


  • Keylyte
    Wallace, India


  • K-Lor
    Abbott, United States


  • Klor-Con
    Upsher-Smith, United States


  • Klotrix
    Bristol-Myers Squibb, United States


  • KSR
    Merck, Indonesia


  • KT
    Jayson, Bangladesh


  • K-Tab
    Abbott, United States


  • Lento-Kalium
    Teofarma, Italy


  • Meinsol Cloruro Potasico
    Fresenius, Spain


  • Micro-K
    Paladin, Canada; Ther-Rx, United States


  • Micro-Kalium retard
    Lannacher, Austria


  • Micro-Kalium
    Lannacher, Austria


  • Miral
    Leiras, Finland


  • Neo-Naclex-K (Potassium Chloride and Bendroflumethiazide)
    Goldshield, United Kingdom


  • Odan K-20
    Odan, Canada


  • Orakit
    Fada, Argentina


  • Plenish-K
    Aspen Pharmacare, South Africa


  • Plus Kalium retard
    Amino, Switzerland


  • Potasio Cloruro
    Sanderson, Chile


  • Potasio
    Natural Life, Argentina


  • Potasion
    Sanofi-Aventis S.A., Spain


  • Potassio cloruro B Braun
    Braun, Italy


  • Potassio cloruro Bioindustria Lim
    Bioindustria Lim, Italy


  • Potassio cloruro Fresenius
    Fresenius, Italy


  • Potassio cloruro Galenica
    Galenica, Italy


  • Potassio cloruro Monico
    Monico, Italy


  • Potassio cloruro Salf
    Salf, Italy


  • Potassium Aguettant
    Aguettant, France


  • Potassium Chloride
    Abbott, United States; Andrx, United States; APP, United States; AstraZeneca, New Zealand; Auden McKenzie, Georgia; Baxter, United States; Biomed, New Zealand; Braun, Estonia; Braun, Lithuania; Braun, United States; Bristol-Myers Squibb, United States; Ethex, United States; Hospira, Canada; Hospira, United States; Major, United States; Pharmaceutical Associates, United States; Pharmatech, Georgia; Phebra, Australia; Schering, United States; United Research, United States; Western Research, United States


  • Potassium Chloride-Fresenius
    Bodene, South Africa


  • Potassium chlorure B.Braun
    Braun, France


  • Potassium chlorure Lavoisier
    Chaix et du Marais, France


  • Potassium Cooper
    Cooper, France


  • Potassium Klorür
    Biofarma, Turkey


  • Potassium Richard
    Richard, France


  • Potasyum Klorür
    Drogsan, Turkey; Galen, Turkey; Koçak, Turkey; Osel, Turkey


  • Rekafarm
    Farmakos, Serbia


  • Rekawan
    Riemser, Germany


  • Rum-K
    Fleming, United States


  • Sabax Potassium Chloride
    Adcock Ingram Critical Care, South Africa


  • Sal Dietetica
    Reccius, Chile


  • Sandoz K-600
    Sandoz, South Africa


  • Slow K
    Novartis, Japan


  • Slow-K
    Alliance, United Kingdom; Novartis, Australia; Novartis, Bermuda; Novartis, Brazil; Novartis, Canada; Novartis, Chile; Novartis, Ghana; Novartis, Guyana; Novartis, Hong Kong; Novartis, Ireland; Novartis, Israel; Novartis, Kenya; Novartis, Libya; Novartis, Malta; Novartis, Malaysia; Novartis, Nigeria; Novartis, Netherlands; Novartis, Sudan; Novartis, Taiwan; Novartis, Tanzania; Novartis, United States; Novartis, South Africa; Novartis, Zimbabwe


  • Solucion de Cloruro de Potasio Richmond
    Richmond, Argentina


  • Soluciones Parenterales
    Fidex, Argentina


  • Solurrinol (Potassium Chloride and Sodium Bicarbonate)
    Teofarma, Spain


  • Span-K
    Aspen, Australia; Aspen, New Zealand


  • Sterile Potassium Chloride Contentrate
    AstraZeneca, Australia; PfizerPerth, Australia


  • Steropotassium
    Sterop, Belgium


  • Ten-K
    Summit Pharmaceuticals, United States


  • Uracyst Test Kit (Potassium Chloride and Chondroitin Polysulfate)
    Stellar, Canada


  • Urirex K (Potassium Chloride and Hydrochlorothiazide)
    Aspen Pharmacare, South Africa

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Ph. Int.Pharmacopoea Internationalis
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 5 August 2010

Doxazosina Neo Sandoz




Doxazosina Neo Sandoz may be available in the countries listed below.


Ingredient matches for Doxazosina Neo Sandoz



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Doxazosina Neo Sandoz in the following countries:


  • Spain

International Drug Name Search

Wednesday, 4 August 2010

Alfin




Alfin may be available in the countries listed below.


Ingredient matches for Alfin



Sildenafil

Sildenafil citrate (a derivative of Sildenafil) is reported as an ingredient of Alfin in the following countries:


  • Chile

International Drug Name Search